Astaxanthin
Natural health product licensed in Canada
- Licence holder
- LKSURE LIMITED
- NPN or DIN-HM
- 80151143
- Status
- Active licence
- Licence date
- 21 September 2026
- Revision date
- 5 October 2026
- Form
- Capsule, molle
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Haematococcus pluvialis Potency : 12 mg Astaxanthin | 120 mg |
| Haematococcus pluvialis | 120 mg |
Non-medicinal ingredients
Glycérine, Eau purifiée, Dioxyde de titane, Gélatine, Huile de coco fractionnée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidants/Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80151143
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.